Synthesis of Uronic Acid 1-Azasugars as Putative Inhibitors of α-Iduronidase, β-Glucuronidase and Heparanase.


Journal

Chembiochem : a European journal of chemical biology
ISSN: 1439-7633
Titre abrégé: Chembiochem
Pays: Germany
ID NLM: 100937360

Informations de publication

Date de publication:
14 02 2023
Historique:
revised: 01 12 2022
received: 27 10 2022
pubmed: 2 12 2022
medline: 16 2 2023
entrez: 1 12 2022
Statut: ppublish

Résumé

1-Azasugar analogues of l-iduronic acid (l-IdoA) and d-glucuronic acid (d-GlcA) and their corresponding enantiomers have been synthesized as potential pharmacological chaperones for mucopolysaccharidosis I (MPS I), a lysosomal storage disease caused by mutations in the gene encoding α-iduronidase (IDUA). The compounds were efficiently synthesized in nine or ten steps from d- or l-arabinose, and the structures were confirmed by X-ray crystallographic analysis of key intermediates. All compounds were inactive against IDUA, although l-IdoA-configured 8 moderately inhibited β-glucuronidase (β-GLU). The d-GlcA-configured 9 was a potent inhibitor of β-GLU and a moderate inhibitor of the endo-β-glucuronidase heparanase. Co-crystallization of 9 with heparanase revealed that the endocyclic nitrogen of 9 forms close interactions with both the catalytic acid and catalytic nucleophile.

Identifiants

pubmed: 36453606
doi: 10.1002/cbic.202200619
doi:

Substances chimiques

Iduronidase EC 3.2.1.76
heparanase EC 3.2.1.-
Uronic Acids 0
Glucuronidase EC 3.2.1.31

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202200619

Informations de copyright

© 2022 The Authors. ChemBioChem published by Wiley-VCH GmbH.

Références

C. S. Hampe, J. B. Eisengart, T. C. Lund, P. J. Orchard, M. Swietlicka, J. Wesley, R. S. McIvor, Cells 2020, 9, 1838.
H. H. Chen, K. Sawamoto, R. W. Mason, H. Kobayashi, S. Yamaguchi, Y. Suzuki, K. Orii, T. Orii, S. Tomatsu, J. Hum. Genet. 2019, 64, 1153-1171.
M. Maccarana, E. Tykesson, E. M. Pera, N. Gouignard, J. Fang, A. Malmstrom, G. Ghiselli, J. P. Li, Glycobiology 2021, 31, 1319-1329.
 
L. Liguori, M. Monticelli, M. Allocca, B. Hay Mele, J. Lukas, M. V. Cubellis, G. Andreotti, Int. J. Mol. Sci. 2020, 21, 489;
D. P. Germain, D. A. Hughes, K. Nicholls, D. G. Bichet, R. Giugliani, W. R. Wilcox, C. Feliciani, S. P. Shankar, F. Ezgu, H. Amartino, D. Bratkovic, U. Feldt-Rasmussen, K. Nedd, U. Sharaf El Din, C. M. Lourenco, M. Banikazemi, J. Charrow, M. Dasouki, D. Finegold, P. Giraldo, O. Goker-Alpan, N. Longo, C. R. Scott, R. Torra, A. Tuffaha, A. Jovanovic, S. Waldek, S. Packman, E. Ludington, C. Viereck, J. Kirk, J. Yu, E. R. Benjamin, F. Johnson, D. J. Lockhart, N. Skuban, J. Castelli, J. Barth, C. Barlow, R. Schiffmann, N. Engl. J. Med. 2016, 375, 545-555.
C. Porto, M. C. Ferrara, M. Meli, E. Acampora, V. Avolio, M. Rosa, B. Cobucci-Ponzano, G. Colombo, M. Moracci, G. Andria, G. Parenti, Mol. Ther. 2012, 20, 2201-2211.
W. C. Cheng, C. K. Lin, H. Y. Li, Y. C. Chang, S. J. Lu, Y. S. Chen, S. Y. Chang, Chem. Commun. (Camb.) 2018, 54, 2647-2650.
J. C. Losada Díaz, J. Cepeda del Castillo, E. A. Rodriguez-López, C. J. Alméciga-Díaz, Int. J. Mol. Sci. 2020, 21, 232.
J. K. Herd, W. R. Mayberry, R. L. Snell, Carbohydr. Res. 1982, 99, 33-39.
I. Cenci di Bello, P. Dorling, L. Fellows, B. Winchester, FEBS Lett. 1984, 176, 61-64.
H. Bie, J. Yin, X. He, A. R. Kermode, E. D. Goddard-Borger, S. G. Withers, M. N. James, Nat. Chem. Biol. 2013, 9, 739-745.
J. Pabba, B. P. Rempel, S. G. Withers, A. Vasella, Helv. Chim. Acta. 2006, 89, 635-666.
C. E. Nieman, A. W. Wong, S. He, J. J. Hopwood, S. G. Withers, Biochemistry 2003, 42, 8054-8065.
O. Lopez, M. Bols, Isofagomine, Noeuromycin and Other 1-Azasugars, Iminosugar Related Glycosidase Inhibitors in Iminosugars: From Synthesis to Therapeutic Applications (Eds.: P. Compain, O. R. Martin), Wiley, 2007, pp. 131-151.
J.-Q. Fan, Iminosugars as Active-Site-Specific Chaperones for the Treatment of Lysosomal Storage Disorders in Iminosugars: From Synthesis to Therapeutic Applications (Eds.: P. Compain, O. R. Martin), Wiley, 2007, pp. 225-247.
A. M. Montaño, N. Lock-Hock, R. D. Steiner, B. H. Graham, M. Szlago, R. Greenstein, M. Pineda, A. Gonzalez-Meneses, M. çoker, D. Bartholomew, M. S. Sands, R. Wang, R. Giugliani, A. Macaya, G. Pastores, A. K. Ketko, F. Ezgü, A. Tanaka, L. Arash, M. Beck, R. E. Falk, K. Bhattacharya, J. Franco, K. K. White, G. A. Mitchell, L. Cimbalistiene, M. Holtz, W. S. Sly, J. Med. Genet. 2016, 53, 403-418.
P. Awolade, N. Cele, N. Kerru, L. Gummidi, E. Oluwakemi, P. Singh, Eur. J. Med. Chem. 2020, 187, 111921.
M. Chhabra, J. C. Wilson, L. Wu, G. J. Davies, N. S. Gandhi, V. Ferro, Chem. Eur. J. 2022, 28, e202104222.
Advances in Experimental Medicine and Biology, Vol. 1221: Heparanase: From Basic Research to Clinical Applications (Eds. I. Vlodavsky, R. D. Sanderson, N. Ilan), Springer, Cham, 2020.
 
Y. Igarashi, M. Ichikawa, Y. Ichikawa, Tetrahedron Lett. 1996, 37, 2707-2708;
Y. Ichikawa, Y. Igarashi, M. Ichikawa, Y. Suhara, J. Am. Chem. Soc. 1998, 120, 3007-3018.
E. D. Goddard-Borger, R. V. Stick, Aust. J. Chem. 2007, 60, 211-213.
E. Lindback, O. Lopez, J. G. Fernandez-Bolanos, S. P. Sauer, M. Bols, Org. Lett. 2011, 13, 2908-2911.
 
C. Kuriyama, O. Kamiyama, K. Ikeda, F. Sanae, A. Kato, I. Adachi, T. Imahori, H. Takahata, T. Okamoto, N. Asano, Bioorg. Med. Chem. 2008, 16, 7330-7336;
S. F. Jenkinson, G. W. J. Fleet, R. J. Nash, Y. Koike, I. Adachi, A. Yoshihara, K. Morimoto, K. Izumori, A. Kato, Org. Lett. 2011, 13, 4064-4067.
M. Kawasaki, F. Matsuda, S. Terashima, Tetrahedron 1988, 44, 5695-5711.
T. K. M. Shing, A. W. F. Wong, T. Ikeno, T. Yamada, J. Org. Chem. 2006, 71, 3253-3263.
A. De Mico, R. Margarita, L. Parlanti, A. Vescovi, G. Piancatelli, J. Org. Chem. 1997, 62, 6974-6977.
N. J. Davis, S. L. Flitsch, Tetrahedron Lett. 1993, 34, 1181-1184.
M. Zhao, J. Li, E. Mano, Z. Song, D. M. Tschaen, E. J. J. Grabowski, P. J. Reider, J. Org. Chem. 1999, 64, 2564-2566.
S. Ranatunga, J. R. Del Valle, Tetrahedron Lett. 2009, 50, 2464-2466.
T. K. M. Shing, Y. C. Leung, K. W. Yeung, Tetrahedron 2003, 59, 2159-2168.
L. Banfi, G. Guanti, M. Paravidino, R. Riva, Org. Biomol. Chem. 2005, 3, 1729-1737.
P. Rybczynski, A. Tretyakov, D. Fuerst, K. Sheth, “New Method for Preparing Isofagomine and Its Derivatives from d-(−)-Arabinose and l-(−)-Xylose”, US20100160638A1, 2010.
K. A. Allen, R. L. Brown, G. Norris, P. C. Tyler, D. K. Watt, O. V. Zubkova, Carbohydr. Res. 2010, 345, 1831-1841.
Y. Cheng, W. H. Prusoff, Biochem. Pharmacol. 1973, 22, 3099-3108.
K. Kok, C.-L. Kuo, R. E. Katzy, L. T. Lelieveld, L. Wu, V. Roig-Zamboni, G. A. van der Marel, J. D. C. Codée, G. Sulzenbacher, G. J. Davies, H. S. Overkleeft, J. M. F. G. Aerts, M. Artola, J. Am. Chem. Soc. 2022, 144, 14819-14827.
E. Oussoren, J. Keulemans, O. P. van Diggelen, L. F. Oemardien, R. G. Timmermans, A. T. van der Ploeg, G. J. G. Ruijter, Mol. Genet. Metab. 2013, 109, 377-381.
L. Ou, T. L. Herzog, C. M. Wilmot, C. B. Whitley, Mol. Genet. Metab. 2014, 111, 113-115.
Y. Nishimura, E. Shitara, H. Adachi, M. Toyoshima, M. Nakajima, Y. Okami, T. Takeuchi, J. Org. Chem. 2000, 65, 2-11.
 
V. Ferro, E. Hammond, J. K. Fairweather, Mini-Rev. Med. Chem. 2004, 4, 693-702;
G. Giannini, G. Battistuzzi, S. Rivara, Adv. Exp. Med. Biol. 2020, 1221, 567-603;
E. Hammond, I. Bytheway, V. Ferro, Heparanase as a Target for Anticancer Therapeutics: New Developments and Future Prospects in New Developments in Therapeutic Glycomics (Eds.: M. Delehedde, H. Lortat-Jacob), Research Signpost, Trivandrum, 2006, pp. 251-282;
C. D. Mohan, S. Hari, H. D. Preetham, S. Rangappa, U. Barash, N. Ilan, S. C. Nayak, V. K. Gupta, Basappa, I. Vlodavsky, K. S. Rangappa, iScience 2019, 15, 360-390.
C. de Boer, Z. Armstrong, V. A. J. Lit, U. Barash, G. Ruijgrok, I. Boyango, M. M. Weitzenberg, S. P. Schroder, A. J. C. Sarris, N. J. Meeuwenoord, P. Bule, Y. Kayal, N. Ilan, J. D. C. Codee, I. Vlodavsky, H. S. Overkleeft, G. J. Davies, L. Wu, Proc. Natl. Acad. Sci. USA 2022, 119, e2203167119.
E. Hammond, C. P. Li, V. Ferro, Anal. Biochem. 2010, 396, 112-116.
G. J. Davies, K. S. Wilson, B. Henrissat, Biochem. J. 1997, 321, 557-559.
 
A. Varrot, C. A. Tarling, J. M. Macdonald, R. V. Stick, D. L. Zechel, S. G. Withers, G. J. Davies, J. Am. Chem. Soc. 2003, 125, 7496-7497;
E. J. Taylor, A. Goyal, C. I. Guerreiro, J. A. Prates, V. A. Money, N. Ferry, C. Morland, A. Planas, J. A. Macdonald, R. V. Stick, H. J. Gilbert, C. M. Fontes, G. J. Davies, J. Biol. Chem. 2005, 280, 32761-32767.
L. Wu, C. M. Viola, A. M. Brzozowski, G. J. Davies, Nat. Struct. Mol. Biol. 2015, 22, 1016-1022.
L. Wu, N. Wimmer, G. J. Davies, V. Ferro, Chem. Commun. (Camb.) 2020, 56, 13780-13783.

Auteurs

Gareth G Doherty (GG)

School of Chemistry & Molecular Biosciences, The University of Queensland, Brisbane, Queensland, 4072, Australia.

Geraldine Jia Ming Ler (GJM)

School of Chemistry & Molecular Biosciences, The University of Queensland, Brisbane, Queensland, 4072, Australia.

Norbert Wimmer (N)

School of Chemistry & Molecular Biosciences, The University of Queensland, Brisbane, Queensland, 4072, Australia.

Paul V Bernhardt (PV)

School of Chemistry & Molecular Biosciences, The University of Queensland, Brisbane, Queensland, 4072, Australia.

Roger A Ashmus (RA)

Department of Chemistry and, Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, V5A 1S6, Canada.

David J Vocadlo (DJ)

Department of Chemistry and, Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, V5A 1S6, Canada.

Zachary Armstrong (Z)

Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK.
Current address: Department of Bio-organic Synthesis, Leiden Institute of Chemistry, Leiden University, 2333 CC, Leiden, The Netherlands.

Gideon J Davies (GJ)

Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK.
Current address: Department of Bio-organic Synthesis, Leiden Institute of Chemistry, Leiden University, 2333 CC, Leiden, The Netherlands.

Marco Maccarana (M)

Department of Medical Biochemistry and Microbiology, The Biomedical Center, University of Uppsala, 75123, Uppsala, Sweden.

Jin-Ping Li (JP)

Department of Medical Biochemistry and Microbiology, The Biomedical Center, University of Uppsala, 75123, Uppsala, Sweden.

Yasmin Kayal (Y)

Technion Integrated Cancer Center (TICC), Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.

Vito Ferro (V)

School of Chemistry & Molecular Biosciences, The University of Queensland, Brisbane, Queensland, 4072, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH